Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Low alkaline phosphatase (ALP) can signal reduced bone mineralization activity, since this enzyme is essential for building and hardening bone tissue. There are several causes and factors to consider. See below to understand more.
ALP is produced by osteoblasts, the cells that form new bone, and it helps break down pyrophosphate so calcium and phosphate can deposit into the bone matrix. When ALP is deficient, pyrophosphate accumulates and blocks mineralization, which can lead to soft, weak bones known as osteomalacia in adults or rickets in children. Common contributors include hypophosphatasia (a genetic ALP deficiency), zinc or magnesium deficiency, malnutrition, hypothyroidism, severe anemia, celiac disease, and certain medications such as bisphosphonates, corticosteroids, or clofibrate. Approved next steps typically involve repeat testing to confirm the low value, checking vitamin B6, calcium, phosphate, magnesium, and zinc levels, evaluating thyroid function, screening for malabsorption, reviewing medications, and considering genetic testing for hypophosphatasia if bone symptoms such as fractures, bone pain, or dental problems are present.
Because low ALP has many possible explanations ranging from easily corrected nutrient gaps to inherited enzyme disorders, and because bone softening can progress silently before fractures occur, understanding your specific pattern of symptoms matters. A free, instant, online symptom check can help you organize what you are experiencing, clarify which follow-up tests may be most relevant, and guide your next conversation with a clinician.
Last reviewed for medical accuracy: 08/18/2026
Alkaline phosphatase (ALP) is an enzyme found throughout the body, especially in the liver, bile ducts, and bone. When you see “what is low alk phos in blood test” on your lab report, it means your ALP level is below the normal range. While high ALP often signals liver or bone overactivity, a low ALP can point to underlying issues—most notably, bone softening (osteomalacia in adults or rickets in children).
Below is a clear, step-by-step guide to understanding low ALP, why it matters for bone health, and what to do next.
Role of ALP
• ALP helps mineralize bone by supporting the deposition of calcium and phosphate into the bone matrix.
• It’s produced by osteoblasts (bone-building cells) and enters the bloodstream.
Normal ALP Ranges
• Adults: roughly 44–147 IU/L (varies by lab).
• Children and adolescents: higher, due to active bone growth.
What Is Low ALK PHOS in Blood Test?
• A reading below the lab’s lower limit.
• Triggers an investigation into potential nutrient deficiencies, genetic conditions, or systemic issues.
When ALP is low, bone mineralization can slow, leading to soft, weak bones. Common causes include:
Nutrient Deficiencies
• Vitamin D deficiency – essential for calcium absorption.
• Magnesium deficiency – cofactor for enzymes including ALP.
• Zinc or copper deficiency – both play roles in bone formation.
Genetic Disorders
• Hypophosphatasia – inherited low ALP activity causing brittle bones, fractures, and dental issues.
Endocrine or Metabolic Conditions
• Hypothyroidism – slows overall metabolism and bone turnover.
• Severe anemia – can impact bone marrow function and ALP production.
Medication Effects
• Certain drugs (e.g., some chemotherapy agents, antiepileptics) can suppress ALP.
Malnutrition or Malabsorption
• Conditions like celiac disease impair nutrient absorption, leading to deficiencies.
Low ALP alone doesn’t diagnose bone softening. Look for:
If you recognize these signs, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help clarify next steps.
To confirm bone softening and its cause, your healthcare provider may recommend:
Repeat and Expand Lab Tests
Imaging Studies
Genetic Testing
Assessment for Malabsorption
Optimize Vitamin D
Balance Calcium and Phosphate
Replete Magnesium, Zinc, Copper
Eat a Well-Rounded Diet
Weight-Bearing Exercise
Address Underlying Conditions
Specific Therapies
Bone softening itself isn’t usually an emergency—but complications can be serious. Contact a healthcare provider or go to the emergency department if you experience:
Always speak to a doctor if you’re worried about anything that could be life-threatening or serious.
If you’re uncertain about your symptoms or lab results, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to clarify your next steps. And remember—always speak to a doctor about anything that feels serious or life-threatening. You don’t have to manage bone health issues alone; medical professionals are there to help you stay strong and safe.
(References)
* Eisman JA. Osteomalacia. Baillieres Clin Endocrinol Metab. 1988 Feb;2(1):125-55. doi: 10.1016/s0950-351x(88)80011-9. PMID: 3044328.
* Nordin BE, Heyburn PJ, Peacock M, Horsman A, Aaron J, Marshall D, Crilly RG. Osteoporosis and osteomalacia. Clin Endocrinol Metab. 1980 Mar;9(1):177-205. doi: 10.1016/s0300-595x(80)80026-0. PMID: 6998609.
* Inoue M. [Hypophosphatasia]. Nihon Rinsho. 2006 Jun 28;Suppl 2:104-7. PMID: 16817361.
* Rockman-Greenberg C. Hypophosphatasia. Pediatr Endocrinol Rev. 2013 Jun;10 Suppl 2:380-8. PMID: 23858621.
* Millán JL, Whyte MP. Alkaline Phosphatase and Hypophosphatasia. Calcif Tissue Int. 2016 Apr;98(4):398-416. doi: 10.1007/s00223-015-0079-1. Epub 2015 Nov 21. PMID: 26590809; PMCID: PMC4824800.
* Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016 Apr;12(4):233-46. doi: 10.1038/nrendo.2016.14. Epub 2016 Feb 19. PMID: 26893260.
* Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, Watsky E, Whyte MP. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone. 2019 Apr;121:149-162. doi: 10.1016/j.bone.2018.12.011. Epub 2018 Dec 18. PMID: 30576866.
* Riancho JA. Diagnostic Approach to Patients with Low Serum Alkaline Phosphatase. Calcif Tissue Int. 2023 Mar;112(3):289-296. doi: 10.1007/s00223-022-01039-y. Epub 2022 Nov 8. PMID: 36348061.
* Reis FS, Lazaretti-Castro M. Hypophosphatasia: from birth to adulthood. Arch Endocrinol Metab. 2023 May 25;67(5):e000626. doi: 10.20945/2359-3997000000626. PMID: 37249457; PMCID: PMC10665056.
* Rush E, Brandi ML, Khan A, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Lewiecki EM, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Starling SR, Ward L, Yao L, Brignardello-Petersen R, Simmons JH. Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group. Osteoporos Int. 2024 Jan;35(1):1-10. doi: 10.1007/s00198-023-06843-2. Epub 2023 Nov 20. PMID: 37982855; PMCID: PMC10786745.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.